Thompson Siegel & Walmsley’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.82M | Buy |
11,086
+1,010
| +10% | +$530K | 0.1% | 193 |
|
|
2025
Q1 | $6.39M | Buy |
10,076
+2,424
| +32% | +$1.54M | 0.11% | 156 |
|
|
2024
Q4 | $5.45M | Buy |
7,652
+162
| +2% | +$115K | 0.08% | 193 |
|
|
2024
Q3 | $7.87M | Sell |
7,490
-1,124
| -13% | -$1.18M | 0.12% | 154 |
|
|
2024
Q2 | $9.05M | Sell |
8,614
-116
| -1% | -$122K | 0.15% | 137 |
|
|
2024
Q1 | $8.4M | Sell |
8,730
-2,431
| -22% | -$2.34M | 0.13% | 151 |
|
|
2023
Q4 | $9.8M | Sell |
11,161
-612
| -5% | -$538K | 0.16% | 131 |
|
|
2023
Q3 | $9.69M | Buy |
11,773
+337
| +3% | +$277K | 0.16% | 130 |
|
|
2023
Q2 | $8.22M | Buy |
11,436
+21
| +0.2% | +$15.1K | 0.13% | 158 |
|
|
2023
Q1 | $9.38M | Buy |
11,415
+423
| +4% | +$348K | 0.15% | 139 |
|
|
2022
Q4 | $7.93M | Sell |
10,992
-411
| -4% | -$297K | 0.13% | 157 |
|
|
2022
Q3 | $7.86M | Sell |
11,403
-96
| -0.8% | -$66.1K | 0.14% | 158 |
|
|
2022
Q2 | $6.8M | Buy |
11,499
+35
| +0.3% | +$20.7K | 0.11% | 167 |
|
|
2022
Q1 | $8.01M | Buy |
11,464
+71
| +0.6% | +$49.6K | 0.11% | 174 |
|
|
2021
Q4 | $7.2M | Buy |
11,393
+313
| +3% | +$198K | 0.1% | 179 |
|
|
2021
Q3 | $6.71M | Buy |
11,080
+235
| +2% | +$142K | 0.1% | 179 |
|
|
2021
Q2 | $6.06M | Buy |
+10,845
| New | +$6.06M | 0.08% | 184 |
|
|
2018
Q2 | – | Sell |
-41
| Closed | -$14K | – | 820 |
|
|
2018
Q1 | $14K | Hold |
41
| – | – | ﹤0.01% | 658 |
|
|
2017
Q4 | $15K | Hold |
41
| – | – | ﹤0.01% | 677 |
|
|
2017
Q3 | $18K | Hold |
41
| – | – | ﹤0.01% | 658 |
|
|
2017
Q2 | $20K | Hold |
41
| – | – | ﹤0.01% | 651 |
|
|
2017
Q1 | $16K | Sell |
41
-6
| -13% | -$2.34K | ﹤0.01% | 662 |
|
|
2016
Q4 | $17K | Hold |
47
| – | – | ﹤0.01% | 607 |
|
|
2016
Q3 | $19K | Hold |
47
| – | – | ﹤0.01% | 588 |
|
|
2016
Q2 | $16K | Buy |
+47
| New | +$16K | ﹤0.01% | 588 |
|